Effects of betaine supplementation on cardiovascular markers: A systematic review and Meta-analysis

References

• Abdelmalek, M. F., S. O. Sanderson, P. Angulo, C. Soldevila-Pico, C. Liu, J. Peter, J. Keach, M. Cave, T. Chen, C. J. McClain, et al. 2009. Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial. Hepatology (Baltimore, Md.) 50 (6):1818–26. doi: 10.1002/hep.23239.
   PubMed Web of Science ®Google Scholar
• Alfthan, G., K. Tapani, K. Nissinen, J. Saarela, and A. Aro. 2004. The effect of low doses of betaine on plasma homocysteine in healthy volunteers. British Journal of Nutrition 92 (4):665–9. doi: 10.1079/BJN20041253.
   PubMed Web of Science ®Google Scholar
• Armstrong, L. E., D. J. Casa, M. W. Roti, E. C. Lee, S. A. S. Craig, J. W. Sutherland, K. A. Fiala, and C. M. Maresh. 2008. Influence of betaine consumption on strenuous running and sprinting in a hot environment. Journal of Strength and Conditioning Research 22 (3):851–60. doi: 10.1519/JSC.0b013e31816a6efb.
   PubMed Web of Science ®Google Scholar
• Atkins, D., D. Best, P. A. Briss, M. Eccles, Y. Falck-Ytter, S. Flottorp, G. H. Guyatt, R. T. Harbour, M. C. Haugh, D. Henry, et al. 2004. Grading quality of evidence and strength of recommendations. BMJ, 328:1490.
   PubMed Web of Science ®Google Scholar
• Atkinson, W., S. Slow, J. Elmslie, M. Lever, S. T. Chambers, P. M. J. N. George, and D. C. Metabolism. 2009. Dietary and supplementary betaine: Effects on betaine and homocysteine concentrations in males. Nutrition, Metabolism and Cardiovascular Diseases 19 (11):767–73. doi: 10.1016/j.numecd.2009.01.004.
   PubMed Web of Science ®Google Scholar
• Baszczuk, A., and Z. Kopczyński. 2014. [Hyperhomocysteinemia in patients with cardiovascular disease]. Postepy Higieny i Medycyny Doswiadczalnej (Online) 68:579–89. doi: 10.5604/17322693.1102340.
   PubMedGoogle Scholar
• Bertoia, M. L., J. K. Pai, J. P. Cooke, M. M. Joosten, M. A. Mittleman, E. B. Rimm, and K. J. Mukamal. 2014. Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. Atherosclerosis 235 (1):94–101. doi: 10.1016/j.atherosclerosis.2014.04.010.
   PubMed Web of Science ®Google Scholar
• Bidulescu, A., L. E. Chambless, A. M. Siega-Riz, S. H. Zeisel, and G. Heiss. 2007. Usual choline and betaine dietary intake and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovascular Disorders 7:20 doi: 10.1186/1471-2261-7-20.
   PubMedGoogle Scholar
• Bloomer, R. J., T. M. Farney, J. F. Trepanowski, C. G. McCarthy, and R. E. Canale. 2011. Effect of betaine supplementation on plasma nitrate/nitrite in exercise-trained men. Journal of the International Society of Sports Nutrition 8:5 doi: 10.1186/1550-2783-8-5.
   PubMed Web of Science ®Google Scholar
• Cercato, C., and F. Fonseca. 2019. Cardiovascular risk and obesity. Diabetol Metab Syndr 11:74 doi: 10.1186/s13098-019-0468-0.
   PubMed Web of Science ®Google Scholar
• Cho, E., S. H. Zeisel, P. Jacques, J. Selhub, L. Dougherty, G. A. Colditz, and W. C. Willett. 2006. Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. The American Journal of Clinical Nutrition 83 (4):905–11. doi: 10.1093/ajcn/83.4.905.
   PubMed Web of Science ®Google Scholar
• Cholewa, J. M., M. Wyszczelska-Rokiel, R. Glowacki, H. Jakubowski, T. Matthews, R. Wood, S. A. S. Craig, and V. Paolone. 2013. Effects of betaine on body composition, performance, and homocysteine thiolactone. Journal of the International Society of Sports Nutrition 10 (1):39. doi: 10.1186/1550-2783-10-39.
   PubMed Web of Science ®Google Scholar
• Cybulska, B., and L. Kłosiewicz-Latoszek. 2015. Homocysteine-is it still an important risk factor for cardiovascular disease? Kardiol Pol 73 (11):1092–6. doi: 10.5603/kp.2015.0229.
   PubMed Web of Science ®Google Scholar
• Dalmeijer, G., M. Olthof, P. Verhoef, M. Bots, and Y. Van der Schouw. 2008. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. European Journal of Clinical Nutrition 62 (3):386–94. doi: 10.1038/sj.ejcn.1602725.
   PubMed Web of Science ®Google Scholar
• Detopoulou, P., D. B. Panagiotakos, S. Antonopoulou, C. Pitsavos, and C. Stefanadis. 2008. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: The ATTICA study. The American Journal of Clinical Nutrition 87 (2):424–30. doi: 10.1093/ajcn/87.2.424.
   PubMed Web of Science ®Google Scholar
• Digitizer, I. P. 2020. How to extract data from graphs using plot digitizer or getdata graph digitizer.
   Google Scholar
• Ejaz, A., L. Martinez-Guino, A. B. Goldfine, F. Ribas-Aulinas, V. De Nigris, S. Ribó, A. Gonzalez-Franquesa, P. M. Garcia-Roves, E. Li, J. M. Dreyfuss, et al. 2016. Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice. Diabetes 65 (4):902–12. doi: 10.2337/db15-1094.
   PubMed Web of Science ®Google Scholar
• Eussen, S. J., P. M. Ueland, R. Clarke, H. J. Blom, W. H. Hoefnagels, W. A. Van Staveren, and L. De Groot. 2007. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. The British Journal of Nutrition 98 (5):960–8. doi: 10.1017/S0007114507750912.
   PubMed Web of Science ®Google Scholar
• Evran, B., A. F. Aydın, B. Uğuralp, M. Sar, S. Doğru-Abbasoğlu, and M. Uysal. 2018. Betaine treatment decreased serum glucose and lipid levels, hepatic and renal oxidative stress in streptozotocin-induced diabetic rats. Turkish Journal of Biochemistry 43 (4):343–51. % . doi: 10.1515/tjb-2016-0183.
   Google Scholar
• Faeh, D., A. Chiolero, and F. Paccaud. 2006. Homocysteine as a risk factor for cardiovascular disease: Should we (still) worry about? Swiss Medical Weekly 136 (47-48):745–56.
   PubMed Web of Science ®Google Scholar
• Ganguly, P., and S. F. Alam. 2015. Role of homocysteine in the development of cardiovascular disease. Nutrition Journal 14:6 doi: 10.1186/1475-2891-14-6.
   PubMed Web of Science ®Google Scholar
• Grizales, A. M., M.-E. Patti, A. P. Lin, J. A. Beckman, V. A. Sahni, E. Cloutier, K. M. Fowler, J. M. Dreyfuss, H. Pan, C. Kozuka, et al. 2018. Metabolic Effects of Betaine: A Randomized Clinical Trial of Betaine Supplementation in Prediabetes. The Journal of Clinical Endocrinology & Metabolism 103 (8):3038–49. doi: 10.1210/jc.2018-00507.
   PubMed Web of Science ®Google Scholar
• Guthikonda, S., and W. G. Haynes. 2006. Homocysteine: Role and implications in atherosclerosis. Current Atherosclerosis Reports 8 (2):100–6. doi: 10.1007/s11883-006-0046-4.
   PubMedGoogle Scholar
• Higgins, J. P. T., D. G. Altman, P. C. Gøtzsche, P. Jüni, D. Moher, A. D. Oxman, J. Savovic, K. F. Schulz, L. Weeks, and J. A. C. Sterne. 2011. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed.) 343:d5928. doi: 10.1136/bmj.d5928.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., J. Thomas, J. Chandler, M. Cumpston, T. Li, M. J. Page, and V. A. Welch. 2019. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons,
   Google Scholar
• Hoffmann, L., G. Brauers, T. Gehrmann, D. Häussinger, E. Mayatepek, F. Schliess, and B. C. Schwahn. 2013. Osmotic regulation of hepatic betaine metabolism. Am J Physiol Gastrointest Liver Physiol 304 (9):G835–46. 8doi: 10.1152/ajpgi.00332.2012.
   PubMed Web of Science ®Google Scholar
• Holm, P. I., P. M. Ueland, S. E. Vollset, Ø. Midttun, H. J. Blom, M. B. A. J. Keijzer, and M. den Heijer. 2005. Betaine and folate status as cooperative determinants of plasma homocysteine in humans. Arteriosclerosis, Thrombosis, and Vascular Biology 25 (2):379–85. doi: 10.1161/01.ATV.0000151283.33976.e6.
   PubMed Web of Science ®Google Scholar
• Howard, B. V., D. C. Robbins, M. L. Sievers, E. T. Lee, D. Rhoades, R. B. Devereux, L. D. Cowan, R. S. Gray, T. K. Welty, O. T. Go, et al. 2000. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology 20 (3):830–5. doi: 10.1161/01.ATV.20.3.830.
   PubMed Web of Science ®Google Scholar
• Ji, C., M. Shinohara, J. Kuhlenkamp, C. Chan, and N. Kaplowitz. 2007. Mechanisms of protection by the betaine-homocysteine methyltransferase/betaine system in HepG2 cells and primary mouse hepatocytes. Hepatology (Baltimore, Md.) 46 (5):1586–96. doi: 10.1002/hep.21854.
   PubMed Web of Science ®Google Scholar
• Kathirvel, E., K. Morgan, G. Nandgiri, B. C. Sandoval, M. A. Caudill, T. Bottiglieri, S. W. French, and T. R. Morgan. 2010. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: A potential mechanism for hepatoprotection by betaine. American Journal of Physiology. Gastrointestinal and Liver Physiology 299 (5):G1068–G1077. doi: 10.1152/ajpgi.00249.2010.
   PubMed Web of Science ®Google Scholar
• Lee, E. C., C. M. Maresh, W. J. Kraemer, L. M. Yamamoto, D. L. Hatfield, B. L. Bailey, L. E. Armstrong, J. S. Volek, B. P. McDermott, S. A. S. Craig, et al. 2010. Ergogenic effects of betaine supplementation on strength and power performance. Journal of the International Society of Sports Nutrition 7 (1):27. doi: 10.1186/1550-2783-7-27.
   PubMed Web of Science ®Google Scholar
• Lever, M., P. M. George, S. Slow, D. Bellamy, J. M. Young, M. Ho, C. J. McEntyre, J. L. Elmslie, W. Atkinson, S. L. Molyneux, et al. 2014. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study. PLoS One 9 (12):e114969 doi: 10.1371/journal.pone.0114969.
   PubMed Web of Science ®Google Scholar
• Li, T., Y. Chen, J. Li, X. Yang, H. Zhang, X. Qin, Y. Hu, and Z. Mo. 2015b. Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors. PLoS One 10 (9):e0138099 doi: 10.1371/journal.pone.0138099.
   PubMed Web of Science ®Google Scholar
• Li, J., B. Li, J. Qi, and B. Shen. 2015a. Meta-analysis of clinical trials of folic acid, vitamin B12 and B6 supplementation on plasma homocysteine level and risk of cardiovascular disease. Zhonghua Xin Xue Guan Bing za Zhi 43:554–61.
   PubMedGoogle Scholar
• Liu, G., P. Bin, T. Wang, W. Ren, J. Zhong, J. Liang, C.-A A. Hu, Z. Zeng, and Y. Yin. 2017. DNA Methylation and the Potential Role of Methyl-Containing Nutrients in Cardiovascular Diseases Oxidative. Oxidative Medicine and Cellular Longevity 2017:1670815 doi: 10.1155/2017/1670815.
   PubMed Web of Science ®Google Scholar
• Li, Z., and D. E. Vance. 2008. Phosphatidylcholine and choline homeostasis. J Lipid Res 49 (6):1187–94. doi: 10.1194/jlr.R700019-JLR200.
   PubMed Web of Science ®Google Scholar
• Martí-Carvajal, A. J., I. Solà, and D. Lathyris. 2015. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 1:CD006612 doi: 10.1002/14651858.CD006612.pub4.
   PubMed Web of Science ®Google Scholar
• Matthews, A., T. N. Johnson, A. Rostami-Hodjegan, A. Chakrapani, J. E. Wraith, S. J. Moat, J. R. Bonham, and G. T. Tucker. 2002. An indirect response model of homocysteine suppression by betaine: Optimising the dosage regimen of betaine in homocystinuria. Br J Clin Pharmacol 54 (2):140–6. doi: 10.1046/j.1365-2125.2002.01620.x.
   PubMed Web of Science ®Google Scholar
• Mc Namara, K., H. Alzubaidi, and J. K. Jackson. 2019. Cardiovascular disease as a leading cause of death: How are pharmacists getting involved? Integrated Pharmacy Research & Practice 8:1–11. doi: 10.2147/IPRP.S133088.
   PubMed Web of Science ®Google Scholar
• McGregor, D. O., W. J. Dellow, R. A. Robson, M. Lever, P. M. George, and S. T. Chambers. 2002. Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney International 61 (3):1040–6. doi: 10.1046/j.1523-1755.2002.00199.x.
   PubMed Web of Science ®Google Scholar
• McRae, M. P. 2013. Betaine supplementation decreases plasma homocysteine in healthy adult participants: A meta-analysis. Journal of Chiropractic Medicine 12 (1):20–5. doi: 10.1016/j.jcm.2012.11.001.
   PubMedGoogle Scholar
• Miglio, F., L. C. Rovati, A. Santoro, and I. Setnikar. 2011. Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. Arzneimittelforschung 50 (08):722–7. doi: 10.1055/s-0031-1300279.
   Google Scholar
• Moher, D., A. Liberati, J. Tetzlaff, and D. G. Altman. 2010. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery (London, England) 8 (5):336–41. doi: 10.1016/j.ijsu.2010.02.007.
   PubMed Web of Science ®Google Scholar
• Moro, T., F. Badiali, I. Fabbri, and A. Paoli. 2020. Betaine Supplementation Does Not Improve Muscle Hypertrophy or Strength Following 6 Weeks of Cross. Nutrients 12 (6):1688. doi: 10.3390/nu12061688.
   Web of Science ®Google Scholar
• Noga, A. A., and D. E. Vance. 2003. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. The Journal of Biological Chemistry 278 (24):21851–9. doi: 10.1074/jbc.M301982200.
   PubMed Web of Science ®Google Scholar
• Noga, A. A., Y. Zhao, and D. E. Vance. 2002. An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. The Journal of Biological Chemistry 277 (44):42358–65. doi: 10.1074/jbc.M204542200.
   PubMed Web of Science ®Google Scholar
• Okura, T., K.-I. Miyoshi, J. Irita, D. Enomoto, T. Nagao, M. Kukida, A. Tanino, K. Kudo, Z. Pei, J. Higaki, et al. 2014. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Scientific Reports 4:5663 doi: 10.1038/srep05663.
   PubMed Web of Science ®Google Scholar
• Olthof, M. R., M. L. Bots, M. B. Katan, and P. Verhoef. 2006. Effect of folic acid and betaine supplementation on flow-mediated dilation: A randomized, controlled study in healthy volunteers. PLoS Clin Trials 1 (2):e10 doi: 10.1371/journal.pctr.0010010.
   PubMedGoogle Scholar
• Olthof, M. R., T. Van Vliet, E. Boelsma, and P. Verhoef. 2003. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. The Journal of Nutrition 133 (12):4135–8. doi: 10.1093/jn/133.12.4135.
   PubMed Web of Science ®Google Scholar
• Olthof, M. R., T. Van Vliet, P. Verhoef, P. L. Zock, and M. B. Katan. 2005. Effect of homocysteine-lowering nutrients on blood lipids: Results from four randomised, placebo-controlled studies in healthy humans. PLoS Med 2 (5):e135 doi: 10.1371/journal.pmed.0020135.
   PubMed Web of Science ®Google Scholar
• Price, R. K., E. M. Keaveney, L. L. Hamill, J. M. W. Wallace, M. Ward, P. M. Ueland, H. McNulty, J. J. Strain, M. J. Parker, R. W. Welch, et al. 2010. Consumption of Wheat Aleurone-Rich Foods Increases Fasting Plasma Betaine and Modestly Decreases Fasting Homocysteine and LDL-Cholesterol in Adults. The Journal of Nutrition 140 (12):2153–7. doi: 10.3945/jn.110.126961.
   PubMed Web of Science ®Google Scholar
• Rajaie, S., and A. Esmaillzadeh. 2011. Dietary choline and betaine intakes and risk of cardiovascular diseases: Review of epidemiological evidence. ARYA Atherosclerosis 7 (2):78–86.
   PubMedGoogle Scholar
• Rajdl, D., J. Racek, L. Trefil, P. Stehlik, J. Dobra, and V. J. N. Babuska. 2016. Effect of folic acid, betaine, vitamin B6, and vitamin B12 on homocysteine and dimethylglycine levels in middle-aged men drinking white wine. Nutrients 8 (1):34. doi: 10.3390/nu8010034.
   PubMed Web of Science ®Google Scholar
• Schaffer, A., M. Verdoia, E. Cassetti, P. Marino, H. Suryapranata, and G. De Luca. 2014. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. Thrombosis Research 134 (2):288–93. doi: 10.1016/j.thromres.2014.05.025.
   PubMed Web of Science ®Google Scholar
• Schwab, U., G. Alfthan, A. Aro, and M. Uusitupa. 2011. Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. Eur J Clin Nutr 65 (1):70–6. doi: 10.1038/ejcn.2010.230.
   PubMed Web of Science ®Google Scholar
• Schwab, U., A. Törrönen, E. Meririnne, M. Saarinen, G. Alfthan, A. Aro, and M. Uusitupa. 2006. Orally administered betaine has an acute and dose-dependent effect on serum betaine and plasma homocysteine concentrations in healthy humans. The Journal of Nutrition 136 (1):34–8. doi: 10.1093/jn/136.1.34.
   PubMed Web of Science ®Google Scholar
• Schwab, U., A. Törrönen, L. Toppinen, G. Alfthan, M. Saarinen, A. Aro, and M. Uusitupa. 2002. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. The American Journal of Clinical Nutrition 76 (5):961–7. doi: 10.1093/ajcn/76.5.961.
   PubMed Web of Science ®Google Scholar
• Schwahn, B. C., D. Hafner, T. Hohlfeld, N. Balkenhol, M. D. Laryea, and U. Wendel. 2003. Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. British Journal of Clinical Pharmacology 55 (1):6–13. doi: 10.1046/j.1365-2125.2003.01717.x.
   PubMed Web of Science ®Google Scholar
• Shorter, K., M. Felder, and P. Vrana. 2015. Consequences of Dietary Methyl Donor Supplements: Is More Always Better? Progress in Biophysics and Molecular Biology 118 (1-2):14–20. doi: 10.1016/j.pbiomolbio.2015.03.007.
   PubMed Web of Science ®Google Scholar
• Sparks, J. D., H. L. Collins, D. V. Chirieac, J. Cianci, J. Jokinen, M. P. Sowden, C. A. Galloway, and C. E. Sparks. 2006. Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase. The Biochemical Journal 395 (2):363–71. doi: 10.1042/BJ20051966.
   PubMedGoogle Scholar
• Steenge, G. R., P. Verhoef, and M. B. Katan. 2003. Betaine supplementation lowers plasma homocysteine in healthy men and women. The Journal of Nutrition 133 (5):1291–5. doi: 10.1093/jn/133.5.1291.
   PubMed Web of Science ®Google Scholar
• Stipanuk, M. H. 2004. Sulfur amino acid metabolism: Pathways for Production and Removal of Homocysteine and Cysteine. Annual Review of Nutrition 24:539–77. doi: 10.1146/annurev.nutr.24.012003.132418.
   PubMed Web of Science ®Google Scholar
• Svingen, G. F. T., H. Schartum-Hansen, E. R. Pedersen, P. M. Ueland, G. S. Tell, G. Mellgren, P. R. Njølstad, R. Seifert, E. Strand, T. Karlsson, et al. 2016. Prospective Associations of Systemic and Urinary Choline Metabolites with Incident Type 2. Clinical Chemistry 62 (5):755–65. doi: 10.1373/clinchem.2015.250761.
   PubMed Web of Science ®Google Scholar
• Tiihonen, K., M. T. Saarinen, E. Alhoniemi, N. Mitsuya, and G. Yamaki. 2016. Effect of dietary betaine on metabolic syndrome risk factors in Asian males with mild fatty liver. Journal of Diabetes Metabolism 7:692. doi: 10.4172/2155-6156.1000692
   Google Scholar
• Trepanowski, J. F., T. M. Farney, C. G. Mccarthy, B. K. Schilling, S. A. Craig, and R. J. Bloomer. 2011. The effects of chronic betaine supplementation on exercise performance, skeletal muscle oxygen saturation and associated biochemical parameters in resistance trained men The. Journal of Strength and Conditioning Research 25 (12):3461–71. doi: 10.1519/JSC.0b013e318217d48d.
   PubMed Web of Science ®Google Scholar
• van Guldener, C., M. J. Janssen, K. de Meer, A. J. Donker, and C. D. Stehouwer. 1999. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. J Intern Med 245 (2):175–83. doi: 10.1046/j.1365-2796.1999.00430.x.
   PubMed Web of Science ®Google Scholar
• van Guldener, C., P. W. Nanayakkara, and C. D. Stehouwer. 2003. Homocysteine and blood pressure. Current Hypertension Reports 5 (1):26–31. doi: 10.1007/s11906-003-0007-z.
   PubMed Web of Science ®Google Scholar
• Velzing-Aarts, F. V., P. I. Holm, M. R. Fokkema, F. P. van der Dijs, P. M. Ueland, and F. A. Muskiet. 2005. Plasma choline and betaine and their relation to plasma homocysteine in normal pregnancy. The American Journal of Clinical Nutrition 81 (6):1383–9. doi: 10.1093/ajcn/81.6.1383.
   PubMed Web of Science ®Google Scholar
• Wan, X., W. Wang, J. Liu, and T. Tong. 2014. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology 14:135 doi: 10.1186/1471-2288-14-135.
   PubMed Web of Science ®Google Scholar
• Wang, L., L. Chen, Y. Tan, J. Wei, Y. Chang, T. Jin, and H. Zhu. 2013. Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein E deficient mice via reducing methylation of peroxisomal proliferator-activated receptor alpha promoter. Lipids Health Dis 12:34 doi: 10.1186/1476-511X-12-34.
   PubMed Web of Science ®Google Scholar
• Yang, M.-T., X.-X. Lee, B.-H. Huang, L.-H. Chien, C.-C. Wang, and K.-H. Chan. 2020. Effects of Two-Week Betaine Supplementation on Apoptosis. Antioxidants 9 (12):1189. doi: 10.3390/antiox9121189.
   Web of Science ®Google Scholar
• Zawieja, E. E., B. Zawieja, and A. Chmurzynska. 2021. Betaine Supplementation Moderately Increases Total Cholesterol Levels: A Systematic Review and Meta. Journal of Dietary Supplements 18 (1):105–13. doi: 10.1080/19390211.2019.1699223.
   PubMedGoogle Scholar
• Zhong, J., G. Agha, and A. A. Baccarelli. 2016. The Role of DNA Methylation in Cardiovascular Risk and Disease: Methodological Aspects, Study Design, and Data Analysis for Epidemiological Studies. Circ Res 118 (1):119–131. doi: 10.1161/CIRCRESAHA.115.305206.
   PubMed Web of Science ®Google Scholar
• Zuo, H. G. F. T., Svingen, G. S. Tell, P. M. Ueland, S. E. Vollset, E. R. Pedersen, A. Ulvik, K. Meyer, J. E. Nordrehaug, D. W. T. Nilsen, et al. 2018. Plasma Concentrations and Dietary Intakes of Choline and Betaine in Association With Atrial Fibrillation Risk: Results From 3 Prospective Cohorts With Different Health Profiles. Journal of the American Heart Association 7 (8), e008190. doi: 10.1161/JAHA.117.008190.
   PubMed Web of Science ®Google Scholar